Encorafenib bulk supplier for pharma manufacturers

Encorafenib 50mg, 75 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 50mg, 75 mg

Reference Brands: Braftovi (USA/EU)

Encorafenib is a targeted anticancer medicine classified as a BRAF kinase inhibitor. It works by blocking the activity of the mutated BRAF V600 protein, which promotes abnormal cell growth in certain cancers. Marketed under the brand name Braftovi, it is available as oral hard capsules in 50 mg and 75 mg strengths. It is mainly used for the treatment of melanoma and metastatic colorectal cancer with a BRAF V600 mutation, often in combination with other targeted therapies such as binimetinib.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Encorafenib — third party manufacturing & bulk supply

Encorafenib 50mg, 75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Encorafenib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Encorafenib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Encorafenib →

Back to Listing

Frequently Asked Questions

Encorafenib is listed as Capsules in 50mg, 75 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Encorafenib is referenced against Braftovi (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.